Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03622983
Recruiting Observational

Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization

NCT03622983 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Started
2017-05-01
Last updated
2022-12-21

Condition(s) studied

Pelvic NeoplasmsEndometriosis

Investigational drug(s) / intervention(s)

collection of sample and data

collection of sample and data: Recovery of surgical waste during surgery planned in the current care and clinical data collection

Study summary

The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence; * Or diagnosis of endometriosis on histology or imaging * Age ≥ 18 years; * Affiliation to the general social security scheme; * Consent signed. Exclusion Criteria: * Refusal of the patient; * Non-affiliation to the general social security scheme.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
CHI Creteil Créteil France Recruiting
CHU Tenon Paris France Recruiting

More Centre Hospitalier Intercommunal Creteil trials in France

National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis Recruiting
Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease Recruiting
Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services Recruiting
Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care Recruiting
Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening Recruiting

Other trials for the same condition

Educational Program for the Multidisciplinary Support of Patients With Endometriosis Recruiting
National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis Recruiting
Diffusion Endometriosis MRI to Detect and Quantify Symptomatic Neurological Impairment in Pelvic Endometriosis Starting soon
Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions Active, not recruiting
Clinical and Molecular Study of Endometriosis and Adenomyosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03622983 on ClinicalTrials.gov ↗ ← All trials in France